“Obesity is a large and growing space with over 200 health conditions associated with it. The proposed acquisition of Metsera aligns with our focus on directing our investments to the most impactful ...
Investor's Business Daily on MSN
Boost Pfizer's already hefty 6% dividend yield with a covered call
Pfizer stock offers a beefy dividend yield. This options strategy makes the drugmaker's yield even more appealing.
Primary endpoint met in first randomized Phase 2 study, FOURLIGHT-1, showing a 40% reduction in the risk of disease progression or death with manageable safety profile More than 90% of patients ...
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 46th Annual Health ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC ("Tutanota") to purchase up to 1 million shares of Pfizer common stock at a ...
Third-quarter 2025 Cost of Sales (3) as a percentage of revenues decreased by 4.7 percentage points compared to the prior-year quarter, primarily driven by (i) a favorable revision of our estimate of ...
The MarketWatch News Department was not involved in the creation of this content. -- Focused Execution Drives Strong Full-Year 2025 EPS Performance -- Enters 2026 with Clear Strategic Priorities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results